Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Diabetes: Page 5
LifeScan, Cecelia Health to offer diabetes support
By
LabPulse.com staff writers
Certified diabetes care and education specialists will offer telehealth through the OneTouch Reveal app, which will be fully integrated into the new portal OneTouch Solutions. In fall 2021, this will be offered to consumers in the U.S. In early 2022, it will be available as a reimbursed adjudicated option to healthcare providers and payors.
August 17, 2021
Ink dries on Hologic's deal to buy Mobidiag
By
LabPulse.com staff writers
Mobidiag's product line includes molecular diagnostic instruments and tests for acute care conditions, including gastrointestinal and respiratory infections, antimicrobial resistance management, and healthcare-associated infections, according to a release.
June 16, 2021
ADA lowers optimal blood sugar levels for kids
By
LabPulse.com staff writers
The recommendation was published in Diabetes Care in a review article by Dr. Maria J. Redondo, a pediatric endocrinologist at Texas Children's Hospital and professor at Baylor College of Medicine, as well as Dr. Sarah Lyons, pediatric endocrinologist at Texas Children's and assistant professor at Baylor College of Medicine.
January 14, 2021
Blood test could predict pregnancy complications
By
LabPulse.com staff writers
A team led by Dr. Sherin Devaskar from the University of California, Los Angeles (UCLA), linked certain cell-free DNA signatures to adverse outcomes in pregnancy, including ischemic placental disease and gestational diabetes.
October 13, 2020
Fujifilm Medical to add IVD to portfolio
By
LabPulse.com staff writers
Fujifilm Wako Diagnostics has developed biomarkers that assess the risk of hepatocellular carcinoma in patients with chronic liver disease, as well as IVD reagents for disorders of lipid metabolism, lupus, rheumatoid arthritis, coronary heart disease, and diabetes, according to Fujifilm Medical Systems.
August 16, 2020
Humana to mail 1M home screening kits amid COVID-19
By
LabPulse.com staff writers
The kits are designed to increase members' access to routine screening tests that they may have put off due to the pandemic. The company is providing them for free to eligible Medicare Advantage members to help identify people with diabetes complications and early signs of colon cancer.
July 23, 2020
Labcorp launches smart laboratory test reports
By
LabPulse.com staff writers
The reports are available for diseases that have significant health risks on their own or as co-morbidities for other conditions, such as diabetes and chronic kidney disease. Labcorp has also created reports for conditions that impact hospitalizations, such as community-acquired methicillin-resistant Staphylococcus aureus (MRSA).
July 8, 2020
Study identifies risk factors for death from coronavirus
By
Abraham Kim
In the observational study, Dr. Bin Cao of Capital Medical University and colleagues from China examined the data of 191 patients with confirmed COVID-19 at two different hospitals. The median age of the patients was 56 and nearly 30% died in the hospitals. They also had various comorbidities, the most common being hypertension (30% of patients), diabetes (19%), and coronary artery disease (8%).
March 10, 2020
Drawbridge's POC HbA1c test cleared for Europe
By
LabPulse.com staff writers
The product is intended for long-term monitoring of blood sugar in adults with diabetes, noted Drawbridge, which is based in Menlo Park, CA. Using the device, medical professionals can collect blood via light vacuum suction as an alternative to methods that involve hypodermic needles or finger sticks. Specimens are taken from the device through a removable cartridge and mailed to a certified lab for analysis.
February 3, 2020
Barbershop POC blood tests pick up undiagnosed diabetes
By
LabPulse.com staff writers
The study involved blood glucose screening with the A1CNow+ test (PTS Diagnostics), with results available in five minutes. Researchers approached 895 men in eight black-owned community barbershops in Brooklyn, New York City, and asked them if they were willing to get tested onsite. The sites were chosen based on whether individuals living in the neighborhoods were likely to have problems with glycemic control and reduced access to primary care.
January 27, 2020
Dexcom, Livongo partner on glucose monitoring
By
LabPulse.com staff writers
The Dexcom G6 CGM system relies on a slim, water-resistant sensor to measure glucose levels beneath the skin of people with diabetes and send the data wirelessly to a server every five minutes. Integrating the CGM data into the Livongo platform will give users access to their personal glucose, blood pressure, and weight data, as well as an analysis of these data based on a combination of clinical expertise and data science, according to the companies.
January 12, 2020
One Drop app predicts blood sugar up to 2 hours in advance
By
LabPulse.com staff writers
Data show that the new model predicted glucose levels within 20% of actual levels in people with type 1 and type 2 diabetes. This information is useful for preventing adverse events associated with a sharp fall or rise in glucose, the company noted.
November 17, 2019
Previous Page
Page 5 of 8
Next Page